ERG2 modulation of immune cells suggests that BPA activation of this cellular pathway can alter immune responses, leading to ERG2-related diseases including lupus-like syndrome, seen in C57BL/6 mice, and allergic airway diseases, seen in BALB/c mice [40,41]. The gene discussed is KCNH6; the disease is drug-induced lupus erythematosus.